Novel tricyclic dihydropyrazines as potassium channel openers

Details for Australian Patent Application No. 2007215005 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Zhang, Xuqing; Sui, Zhihua

Agent Shelston IP

Pub. Number AU-A-2007215005

PCT Pub. Number WO2007/095424

Priority 60/772,508 10.02.06 US

Filing date 1 February 2007

Wipo publication date 23 August 2007

International Classifications

C07D 241/38 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

A61K 31/498 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 13/00 (2006.01) Drugs for disorders of the urinary system

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

28 August 2008 PCT application entered the National Phase

  PCT publication WO2007/095424 Priority application(s): WO2007/095424

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007215012-Antibody formulation

2007215004-Bicyclic imidazole or thiadiazole heterocycles useful as selective androgen receptor modulators